IMVT
Immunovant, Inc. · Healthcare
General Counsel Mark S. Levine sold $85K of Immunovant, Inc.
Sold$84,725
$21.63Price
3,917Shares
−1%Stake
What IMVT did after the filing
- The stock from Thu, Jul 27 close, $21.73
- +7.3%
- S&P 500, same days
- −1.5%
Measured over 30 trading days, to the Sep 8 close.
Traded Wed, Jul 26. Filed Thu, Jul 27, 12:33 PM ET, during the session. Returns use the Jul 27 close and the Sep 8 close. Not investment advice.